Pure Global AI
NCT06420700Recruiting

Ablation Registry (Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty for Weight Loss)

A Multi-site, Prospective Registry of Patients Undergoing Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty at True You Weight Loss
True You Weight LossClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Obesity
Drug/Device/Intervention
Combined gastric mucosal ablation with endoscopic sleeve gastroplasty
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
True You Weight Loss
Location
Atlanta,Cary, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 31, 2024
End date
Jan 31, 2028
Enrollment
100 participants
Primary outcome

Percent Change in Total Body Weight Loss (TBWL) from Baseline

Summary

The purpose of this study is to construct a multi-site, prospective registry to evaluate the
 clinical outcomes of patients who have undergone combined gastric mucosal ablation with
 endoscopic sleeve gastroplasty at True You Weight Loss.

ICD-10 classifications
ObesityOther obesityObesity, unspecifiedObesity due to excess caloriesObesity and other hyperalimentation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06420700
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06420700 through Pure Global AI's free database. This phase not specified trial is sponsored by True You Weight Loss and is currently Recruiting. The study focuses on Obesity. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.